SOD3 and eNOS genotypes are associated with SOD activity and NOx

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 328-334

  Dong, Xiao Long ^a   Li, De Jun ^a   Liu, Hong ^a   Zhao, Yan Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hypertension; Nitric oxide synthase; Oxidative stress; Polymorphism; Superoxide dismutase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN OXIDE; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; CALORIMETRY; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; GLUCOSE BLOOD LEVEL; HAN CHINESE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84901325519     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1720     Document Type: Article

References (48)

1. Panza JA, Quyyumi AA, Brush JE Jr and Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990.
2. Panza JA, Casino PR, Kilcoyne CM and Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474, 1993.
3. Perticone F, Ceravolo R, Pujia A and et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191-196, 2001.
4. Le Brocq M, Leslie SJ, Milliken P and Megson IL: Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal 10: 1631-1674, 2008.
5. Strålin P, Karlsson K, Johansson BO and Marklund SL: The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15: 2032-2036, 1995.
6. Kuzkaya N, Weissmann N, Harrison DG and Dikalov S: Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
7. Laursen JB, Somers M, Kurz S, et al: Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
8. Houston MC: The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis 4: 165-183, 2010.
9. Sherman DL, Keaney JF Jr, Biegelsen ES, et al: Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35: 936-941, 2000.
10. Engelhard YN, Gazer B and Paran E: Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 151: 100, 2006.
11. Block G, Mangels AR, Norkus EP, et al: Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 37: 261-267, 2001.
12. Ward NC, Wu JH, Clarke MW, et al: The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25: 227-234, 2007.
13. Taniguchi N: Superoxide dismutases: significances in aging, diabetes, ischemia and cancer. Rinsho Byori 38: 876-881, 1990 (In Japanese).
14. Autor AP, Frank L and Roberts RJ: Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res 10: 154-158, 1976.
15. Skrzycki M, Majewska M, Podsiad M and Czeczot H: Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta Biochim Pol 56: 663-670, 2009.
16. Adler S and Huang H: Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287: F907-F913, 2004.
17. Chu Y, Iida S, Lund DD, et al: Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 92: 461-468, 2003.
18. Zhou L, Xiang W, Potts J, et al: Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 41: 1384-1391, 2006.
19. Kumar CA and Das UN: Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Med Sci Monit 6: 901-907, 2000.
20. Djordjević VB, Pavlović D, Pejović M, et al: Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors. Clin Nephrol 47: 243-247, 1997.
21. Koska J, Syrova D, Blazicek, et al: Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J Hypertens 17: 529-535, 1999.
22. Yamada H, Yamada Y, Adachi T, et al: Polymorphism of extracellular superoxide dismutase (EC-SOD) gene: relation to the mutation responsible for high EC-SOD level in serum. Jpn J Hum Genet 42: 353-356, 1997.
23. Campo S, Sardo AM, Campo GM, et al: Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat Res 578: 143-148, 2005.
24. Sandström J, Nilsson P, Karlsson K and Marklund SL: 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 269: 19163-19166, 1994.
25. Marklund SL, Nilsson P, Israelsson K, et al: Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 242: 5-14, 1997.
26. Adachi T and Wang XL: Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism. FEBS Lett 433: 166-168, 1998.
27. Yamada H, Yamada Y, Adachi T, et al: Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum. Jpn J Hum Genet 40: 177-184, 1995.
28. Iida R, Tsubota E, Takeshita H and Yasuda T: Multiplex single base extension method for simultaneous genotyping of non-synonymous SNP in the three human SOD genes. Electrophoresis 29: 4788-4794, 2008.
29. Ferroni P, Basili S, Paoletti V and Davì G: Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16: 222-233, 2006.
30. Node K, Kitakaze M, Yoshikawa H, Kosaka H and Hori M: Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 30: 405-408, 1997.
31. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS and Tanus-Santos JE: Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16: 348-355, 2007.
32. Raman CS, Li H, Martásek P, et al: Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95: 939-950, 1998.
33. Moon J, Yoon S, Kim E, et al: Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb Res 107: 129-134, 2002.
34. Metzger IF, Souza-Costa DC, Marroni AS, et al: Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15: 565-570, 2005.
35. Li R, Lyn D, Lapu-Bula R, et al: Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens 17: 560-567, 2004.
36. Yoon Y, Song J, Hong SH and Kim JQ: Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46: 1626-1630, 2000.
37. Song J, Yoon Y, Park KU, et al: Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem 49: 847-852, 2003.
38. Metzger IF, Sertório JT and Tanus-Santos JE: Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43: 987-992, 2007.
39. Tamai M, Furuta H, Kawashima H, et al: Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract 71: 140-145, 2006.
40. Samoila OC, Carter AM, Futers ST, et al: Polymorphic variants of extracellular superoxide dismutase gene in a Romanian population with atheroma. Biochem Genet 46: 634-643, 2008.
41. Mansego ML, Solar Gde M, Alonso MP, et al: Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens 29: 492-500, 2011.
42. Naganuma T, Nakayama T, Sato N, et al: A haplotype-based case-control study examining human extracellular superoxide dismutase gene and essential hypertension. Hypertens Res 31: 1533-1540, 2008.
43. Miyamoto Y, Saito Y, Kajiyama N, et al: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8, 1998.
44. Lacolley P, Gautier S, Poirier O, et al: Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16: 31-35, 1998.
45. Kato N, Sugiyama T, Morita H, et al: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33: 933-936, 1999.
46. Benjafield AV and Morris BJ: Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 13: 994-998, 2000.
47. Kingah PL, Luu HN, Volcik KA, et al: Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study. Hypertens Res 33: 165-169, 2010.
48. Zhao Q, Su SY, Chen SF, Li B and Gu DF: Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med J (Engl) 119: 1065-1071, 2006.